Vemurafenib is a pyrrolopyridine-based sulfonamide compound that acts as a B-Raf kinase inhibitor. It is used as an active pharmaceutical ingredient in antineoplastic applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vemurafenib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Zelboraf
pharmaceutical raw material
N-[3-[(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide
pharmaceutical intermediate
Lithium citrate
pharmaceutical raw material
Phenothiazine
pharmaceutical raw material
Setmelanotide
pharmaceutical raw material
Resmetirom
pharmaceutical raw material
The international HS code for Vemurafenib (CAS 918504-65-1) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide
GPXBXXGIAQBQNI-UHFFFAOYSA-N
CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F
Sourcing Vemurafenib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.